KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Depreciation & Amortization (CF): 2017-2025

Historic Depreciation & Amortization (CF) for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $24.9 million.

  • Twist Bioscience's Depreciation & Amortization (CF) fell 9.80% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year decrease of 20.93%. This contributed to the annual value of $24.9 million for FY2025, which is 20.93% down from last year.
  • Per Twist Bioscience's latest filing, its Depreciation & Amortization (CF) stood at $24.9 million for FY2025, which was down 20.93% from $31.4 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Depreciation & Amortization (CF) registered a high of $31.4 million during FY2024, and its lowest value of $9.8 million during FY2021.
  • Over the past 3 years, Twist Bioscience's median Depreciation & Amortization (CF) value was $29.3 million (recorded in 2023), while the average stood at $28.5 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 77.49% in 2023, then declined by 20.93% in 2025.
  • Over the past 5 years, Twist Bioscience's Depreciation & Amortization (CF) (Yearly) stood at $9.8 million in 2021, then spiked by 68.51% to $16.5 million in 2022, then soared by 77.49% to $29.3 million in 2023, then grew by 7.24% to $31.4 million in 2024, then dropped by 20.93% to $24.9 million in 2025.